Mersana Therapeutics(MRSN) - 2024 Q2 - Earnings Call Transcript

Mersana Therapeutics, Inc. (NASDAQ:MRSN) Q2 2024 Earnings Conference Call August 13, 2024 8:00 AM ET Company Participants Martin Huber - President & CEO Brian DeSchuytner - CFO & COO Jason Fredette - SVP, IR Conference Call Participants Tara Bancroft - TD Cowen Jonathan Chang - Leerink Partners Ashiq Mubarack - Citi Michael Schmidt - Guggenheim Charles Zhu - LifeSci Capital Colleen Kusy - Robert W. Baird Brian Cheng - J.P. Morgan Asthika Goonewardene - Truist Securities Justin Zelin - BTIG Operator Good mor ...